User: Guest  Login
Title:

SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.

Document type:
Journal Article; Article; Proceedings Paper
Author(s):
De-Colle, Chiara; Menegakis, Apostolos; Mönnich, David; Welz, Stefan; Boeke, Simon; Sipos, Bence; Fend, Falko; Mauz, Paul-Stefan; Tinhofer, Inge; Budach, Volker; Abu Jawad, Jehad; Stuschke, Martin; Balermpas, Panagiotis; Rödel, Claus; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Belka, Claus; Ganswindt, Ute; Pigorsch, Steffi; Combs, Stephanie E; Lohaus, Fabian; Linge, Annett; Krause, Mechthild; Baumann, Michael; Zips, Daniel
Abstract:
INTRODUCTION: Preclinical and clinical data suggest that the chemokine pathway governed by SDF-1 and CXCR4 contributes to a resistant phenotype. This retrospective biomarker study aims to explore the specific prognostic value of SDF-1 and CXCR4 expression in locally advanced head and neck squamous cell carcinomas (HNSCC) treated with primary radiochemotherapy (RT-CT). MATERIAL AND METHODS: Biopsies from 141 HNSCC tumours of the oral cavity, oropharynx and hypopharynx were evaluated for SDF-1 and...     »
Journal title abbreviation:
Radiother Oncol
Year:
2018
Journal volume:
126
Journal issue:
1
Pages contribution:
125-131
Language:
eng
Fulltext / DOI:
doi:10.1016/j.radonc.2017.10.008
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/29061496
Print-ISSN:
0167-8140
TUM Institution:
Klinik und Poliklinik für RadioOnkologie und Strahlentherapie
 BibTeX